Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan trial in mildly symptomatic pulmonary arterial hypertension
2004-000478-30Phase 3Completed
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Jul 2004
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in pulmonary arterial hypertension (PAH) comparing Bosentan with Placebo (2 arms). Primary endpoints: Exercise capacity and Cardiac hemodynamics. Started Jul 2004; status: completed.
02
Drugs
bosentan
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on 2004-000478-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000478-30.